| Serial Number | 79425415 |
| Word Mark | REJUVANAD+ |
| Filing Date | Friday, April 11, 2025 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Monday, June 8, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, June 30, 2026 |
| Pseudo Mark | REJUVANAD PLUS |
| Goods and Services | Pharmaceutical preparations for the treatment of age-related cellular decline; pharmaceutical preparations for anti-aging purposes; pharmaceutical preparations for cognitive enhancement and mental clarity; pharmaceutical preparations for boosting energy levels and treating fatigue; pharmaceutical preparations for supporting DNA repair; pharmaceutical preparations for cellular rejuvenation and metabolic support; pharmaceutical preparations for physical recovery; Pharmaceutical compositions, namely, nicotinamide adenine dinucleotide (NAD+) preparations for medical use, namely, for the treatment of cellular aging; pharmaceutical compositions, namely, coenzyme preparations for medical use, namely, for the treatment of cellular aging; pharmaceutical compositions, namely, anti-aging pharmaceutical preparations for the treatment of cellular aging; Pharmaceutical drugs for the treatment of age-related cellular decline; pharmaceutical drugs for the treatment of fatigue; pharmaceutical drugs for the treatment of cognitive impairment; pharmaceutical drugs for the treatment of metabolic disorders; Cough pastilles for medical use; Medicinal infusions for treating fatigue and age-related conditions; Medicine preparations for human use for anti-aging purposes; medicine preparations for human use for cellular health support; medicine preparations for human use for the treatment of age-related conditions and fatigue; Non-prescription medicine preparations for general health and wellness support; non-prescription medicine preparations for anti-aging support; non-prescription medicine preparations for energy and vitality support; Pre-filled syringes containing nicotinamide adenine dinucleotide (NAD+) for medical purposes; prefilled syringes containing pharmaceutical preparations for anti-aging and cellular rejuvenation, for medical purposes; Pharmaceutical preparations for antiaging skin care; Anti-aging pharmaceutical compositions for skin care; Pharmaceutical preparations for skin care; Medicated skin care preparations for medical purposes; Medicated skin care preparations; Injectable dermal fillers for medical purposes; Medicated creams for skin care and protection of the skin; all the foregoing containing nicotinamide adenine dinucleotide |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 5, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | NOT AVAILABLE |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 01 - Individual |
| Address | KR |
| Event Date | Event Description |
| Thursday, June 5, 2025 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, June 6, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, June 6, 2025 | APPLICATION FILING RECEIPT MAILED |
| Monday, September 8, 2025 | ASSIGNED TO EXAMINER |
| Monday, September 8, 2025 | NON-FINAL ACTION WRITTEN |
| Tuesday, September 9, 2025 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Monday, October 27, 2025 | REFUSAL PROCESSED BY MPU |
| Monday, October 27, 2025 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Saturday, November 15, 2025 | REFUSAL PROCESSED BY IB |
| Monday, April 27, 2026 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Monday, April 27, 2026 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Monday, April 27, 2026 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, April 27, 2026 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, April 27, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, April 27, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, April 27, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, May 22, 2026 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, May 22, 2026 | EXAMINERS AMENDMENT E-MAILED |
| Friday, May 22, 2026 | EXAMINER'S AMENDMENT ENTERED |
| Friday, May 22, 2026 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, June 1, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, June 10, 2026 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, June 10, 2026 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, June 24, 2026 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, June 25, 2026 | NOTIFICATION PROCESSED BY IB |